Update: 28.01.2024
Last week: 3 week 2024 (13.12.2024 - 19.01.2025)
Last full month: December 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 185 | 14.1% | 12.6% | -0.8 | 16 787 487 | 15.9% | 9.1% | -0.4 | 21.1% |
| MoM | 39 753 | -10.9% | 13.5% | 0.2 | 76 154 633 | -3.6% | 9.5% | 0.5 | -12.4% |
| YTD | 21 150 | 24.7% | 13.1% | 2 | 42 704 665 | 12.8% | 9.4% | -0.2 | 5.7% |
| MAT | 425 639 | 23.7% | 12.4% | 3.2 | 843 945 558 | 25.9% | 9.3% | 1.5 | -7.9% |
| BRAINMAX | |||||||||
| WoW | 2 152 | 10.3% | 100.0% | 0 | 7 821 851 | 8.2% | 100.0% | 0 | 10.3% |
| MoM | 10 252 | -12.4% | 100.0% | 0 | 35 144 895 | -9.6% | 100.0% | 0 | -12.4% |
| YTD | 5 445 | 93.4% | 100.0% | 0 | 19 699 725 | 98.3% | 100.0% | 0 | 93.4% |
| MAT | 85 296 | 77.2% | 100.0% | 0 | 296 485 705 | 78.1% | 100.0% | 0 | 77.2% |
| GOLDLINE PLUS | |||||||||
| WoW | 16 748 | 7.3% | 45.6% | -0.1 | 54 793 971 | 9.6% | 38.1% | 0.5 | 7.5% |
| MoM | 59 737 | -4.8% | 46.6% | -0.8 | 189 099 862 | -3.4% | 37.9% | -0.8 | -3.1% |
| YTD | 41 822 | -5.9% | 45.7% | 2 | 134 967 942 | -7.6% | 37.9% | 1.4 | -9.9% |
| MAT | 826 497 | -5.1% | 45.5% | 0.5 | 2 591 654 422 | -4.3% | 37.2% | -2.4 | -6.2% |
| MIGRENIUM | |||||||||
| WoW | 7 831 | 15.2% | 0.3% | 0 | 2 743 220 | 15.8% | 0.5% | 0 | 9.8% |
| MoM | 36 820 | -10.5% | 0.4% | -0.1 | 12 854 774 | -8.7% | 0.5% | -0.1 | 5.1% |
| YTD | 21 410 | -33.3% | 0.3% | -0.1 | 7 481 961 | -9.9% | 0.5% | -0.1 | -4.2% |
| MAT | 557 140 | -12.7% | 0.5% | -0.1 | 180 826 552 | 45.2% | 0.6% | 0.1 | 2.5% |
| MODELAX-N | |||||||||
| WoW | 31 600 | 2.7% | 20.5% | -2.1 | 16 333 657 | 2.9% | 14.5% | -1.2 | 13.3% |
| MoM | 116 997 | -2.5% | 18.7% | -1.9 | 59 395 533 | -0.1% | 13.0% | -0.8 | 7.3% |
| YTD | 86 328 | 14.3% | 21.1% | 1.9 | 44 316 687 | 49.4% | 14.7% | 3.4 | 3.9% |
| MAT | 1 474 373 | 23.4% | 21.8% | 3 | 673 910 958 | 70.1% | 14.3% | 3.9 | 6.5% |
| REDUXIN | |||||||||
| WoW | 11 724 | 9.0% | 31.9% | 0.4 | 62 306 453 | 8.8% | 43.3% | 0.2 | 7.5% |
| MoM | 40 558 | -3.1% | 31.6% | 0 | 218 912 186 | -1.4% | 43.9% | 0 | -3.1% |
| YTD | 29 098 | -15.6% | 31.8% | -2.1 | 154 417 381 | -17.4% | 43.3% | -3.3 | -9.9% |
| MAT | 590 102 | -7.3% | 32.5% | -0.4 | 3 130 820 338 | 7.5% | 45.0% | 2.4 | -6.2% |
| REDUXIN FORTE | |||||||||
| WoW | 3 629 | 12.4% | 9.9% | 0.4 | 16 164 767 | 5.9% | 11.2% | -0.2 | 7.5% |
| MoM | 12 480 | -1.0% | 9.7% | 0.2 | 55 829 134 | 4.2% | 11.2% | 0.6 | -3.1% |
| YTD | 8 860 | 4.3% | 9.7% | 1.3 | 40 259 001 | 9.0% | 11.3% | 2.1 | -9.9% |
| MAT | 167 719 | 1.1% | 9.2% | 0.7 | 725 023 512 | 10.1% | 10.4% | 0.8 | -6.2% |
| SALVISAR | |||||||||
| WoW | 13 755 | 22.1% | 1.8% | 0.2 | 6 603 071 | 26.0% | 1.7% | 0.2 | 10.8% |
| MoM | 57 672 | -11.6% | 1.8% | -0.2 | 26 098 698 | -10.0% | 1.7% | -0.1 | -3.0% |
| YTD | 35 985 | 61.0% | 1.8% | 0.8 | 16 772 779 | 118.9% | 1.7% | 0.8 | -7.0% |
| MAT | 585 413 | 19.7% | 1.5% | 0.3 | 250 052 554 | 55.1% | 1.4% | 0.4 | -4.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 21 150 | 24.7% | 13.1% | 2 | 42 704 665 | 12.8% | 9.4% | -0.2 | 5.7% |
| BRAINMAX | 5 445 | 93.4% | 100.0% | 0 | 19 699 725 | 98.3% | 100.0% | 0 | 93.4% |
| GOLDLINE PLUS | 41 822 | -5.9% | 45.7% | 2 | 134 967 942 | -7.6% | 37.9% | 1.4 | -9.9% |
| MIGRENIUM | 21 410 | -33.3% | 0.3% | -0.1 | 7 481 961 | -9.9% | 0.5% | -0.1 | -4.2% |
| MODELAX-N | 86 328 | 14.3% | 21.1% | 1.9 | 44 316 687 | 49.4% | 14.7% | 3.4 | 3.9% |
| REDUXIN CAPS | 29 098 | -15.6% | 31.8% | -2.1 | 154 417 381 | -17.4% | 43.3% | -3.3 | -9.9% |
| REDUXIN FORTE | 8 860 | 4.3% | 9.7% | 1.3 | 40 259 001 | 9.0% | 11.3% | 2.1 | -9.9% |
| SALVISAR | 35 985 | 61.0% | 1.8% | 0.8 | 16 772 779 | 118.9% | 1.7% | 0.8 | -7.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 425 639 | 23.7% | 12.4% | 3.2 | 843 945 558 | 25.9% | 9.3% | 1.5 | -7.9% |
| BRAINMAX | 85 296 | 77.2% | 100.0% | 0 | 296 485 705 | 78.1% | 100.0% | 0 | 77.2% |
| GOLDLINE PLUS | 826 497 | -5.1% | 45.5% | 0.5 | 2 591 654 422 | -4.3% | 37.2% | -2.4 | -6.2% |
| MIGRENIUM | 557 140 | -12.7% | 0.5% | -0.1 | 180 826 552 | 45.2% | 0.6% | 0.1 | 2.5% |
| MODELAX-N | 1 474 373 | 23.4% | 21.8% | 3 | 673 910 958 | 70.1% | 14.3% | 3.9 | 6.5% |
| REDUXIN CAPS | 590 102 | -7.3% | 32.5% | -0.4 | 3 130 820 338 | 7.5% | 45.0% | 2.4 | -6.2% |
| REDUXIN FORTE | 167 719 | 1.1% | 9.2% | 0.7 | 725 023 512 | 10.1% | 10.4% | 0.8 | -6.2% |
| SALVISAR | 585 413 | 19.7% | 1.5% | 0.3 | 250 052 554 | 55.1% | 1.4% | 0.4 | -4.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 185 | 14.1% | 12.6% | -0.8 | 16 787 487 | 15.9% | 9.1% | -0.4 | 21.1% |
| BRAINMAX | 2 152 | 10.3% | 100.0% | 0 | 7 821 851 | 8.2% | 100.0% | 0 | 10.3% |
| GOLDLINE PLUS | 16 748 | 7.3% | 45.6% | -0.1 | 54 793 971 | 9.6% | 38.1% | 0.5 | 7.5% |
| MIGRENIUM | 7 831 | 15.2% | 0.3% | 0 | 2 743 220 | 15.8% | 0.5% | 0 | 9.8% |
| MODELAX-N | 31 600 | 2.7% | 20.5% | -2.1 | 16 333 657 | 2.9% | 14.5% | -1.2 | 13.3% |
| REDUXIN CAPS | 11 724 | 9.0% | 31.9% | 0.4 | 62 306 453 | 8.8% | 43.3% | 0.2 | 7.5% |
| REDUXIN FORTE | 3 629 | 12.4% | 9.9% | 0.4 | 16 164 767 | 5.9% | 11.2% | -0.2 | 7.5% |
| SALVISAR | 13 755 | 22.1% | 1.8% | 0.2 | 6 603 071 | 26.0% | 1.7% | 0.2 | 10.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 39 753 | -10.9% | 13.5% | 0.2 | 76 154 633 | -3.6% | 9.5% | 0.5 | -12.4% |
| BRAINMAX | 10 252 | -12.4% | 100.0% | 0 | 35 144 895 | -9.6% | 100.0% | 0 | -12.4% |
| GOLDLINE PLUS | 59 737 | -4.8% | 46.6% | -0.8 | 189 099 862 | -3.4% | 37.9% | -0.8 | -3.1% |
| MIGRENIUM | 36 820 | -10.5% | 0.4% | -0.1 | 12 854 774 | -8.7% | 0.5% | -0.1 | 5.1% |
| MODELAX-N | 116 997 | -2.5% | 18.7% | -1.9 | 59 395 533 | -0.1% | 13.0% | -0.8 | 7.3% |
| REDUXIN CAPS | 40 558 | -3.1% | 31.6% | 0 | 218 912 186 | -1.4% | 43.9% | 0 | -3.1% |
| REDUXIN FORTE | 12 480 | -1.0% | 9.7% | 0.2 | 55 829 134 | 4.2% | 11.2% | 0.6 | -3.1% |
| SALVISAR | 57 672 | -11.6% | 1.8% | -0.2 | 26 098 698 | -10.0% | 1.7% | -0.1 | -3.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs